Skip to main content
NIH funding notice RFA-NS-22-017

Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)

Closed on November 12, 2021.

Posted
September 10, 2021
Close date
November 12, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,955,795 in first-year total cost, median $6,955,795.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-O (17)]1

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL1
Competing awards under RFA-NS-22-017 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022VCID Biomarkers Coordinating Center2U24NS100591-06A1GREENBERG, STEVEN MMASSACHUSETTS GENERAL HOSPITAL, MA$6,955,795ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.